Basic Information
Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA. Sensible's platform eliminates major bottlenecks in the mRNA production process, striving to unlock the full potential of mRNA technology as well as next-generation mRNA therapies and vaccines. Sensible aims to become an integral part of the global biomanufacturing infrastructure and biosecurity framework.
Sensible Biotechnologies, Inc.
Slovakia
15~50 people
January 01, 2021
info@sensible.bio

